Clinical trial
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in…
NCT00002926 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status
Key facts
| NCT number | NCT00002926 |
|---|---|
| Title | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia |
| Official title | Autologous Peripheral Blood Stem Cell Transplantation (PSCT) Versus a Second Intensive Consolidation Course After a Common Induction and Consolidation Course in Patients With Bad Prognosis Myelodysplastic Syndromes (MDS) and Acute Myelogenous Leukemia Secondary (SAML) to MDS of More Acute Than 6… |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Drug, Procedure |
| Interventions | cytarabine, etoposide, idarubicin, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 80 |
| Start date | Dec 1, 1996 |
| First posted | Jan 27, 2003 |
| Last update posted | May 27, 2010 |
| Countries | Belgium, Croatia, Czechia, France, Germany, Italy, Netherlands, Sweden, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: